VVOS — Vivos Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1716166 ·
Last close
$0.43
Market Cap
$6.00M
52W High
$1.54
52W Low
$0.38
ADV30
3,224,406
Next earnings
2026-08-14
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 5,141,000 | 3,059,000 | -6,615,000 | -7,751,000 | 25,043,000 | 2,110,000 | 26,310,000 |
| Dec 2025 | 3,824,000 | 2,988,000 | -6,382,000 | -6,954,000 | 25,152,000 | 2,029,000 | 26,702,000 |
| Sep 2025 | 6,783,000 | 3,937,000 | -4,734,000 | -5,400,000 | 25,644,000 | 3,087,000 | 23,112,000 |
| Jun 2025 | 3,820,000 | 2,110,000 | -4,865,000 | -5,013,000 | 26,033,000 | 4,402,000 | 21,450,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-17,477,000
Investing CF
$-7,422,000
Financing CF
$24,667,000
CapEx
$-2,442,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.01
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-133,039,000
Inventory
—
Receivables
$1,769,000
ST Investments
—
EBIT TTM
$-22,596,000
Pretax Income TTM
$-25,118,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$19,568,000
EBITDA
$-21,005,000
Free Cash Flow
$-10,076,375
Enterprise Value
$16,498,326
Total Cash
$2,110,000
Total Debt
$12,268,000
Shares Out
13,894,600
Trailing EPS
$-2.14
Book Value
$0.31
ROE
-1599.8%
ROA
-77.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 17,443,000 | -19,894,000 | -21,230,000 | 25,152,000 | 26,702,000 | — | -15,263,000 |
| Dec 2024 | 15,031,000 | -11,171,000 | -11,136,000 | 15,284,000 | 7,330,000 | — | -12,691,000 |
| Dec 2023 | 13,801,000 | -17,296,000 | -13,583,000 | 10,730,000 | 10,319,000 | — | -11,946,000 |
| Dec 2022 | 16,024,000 | -25,031,000 | -23,845,000 | 13,720,000 | 8,919,000 | — | -19,587,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.79
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| XAIR | Beyond Air, Inc. | $6.01M | $0.42 | — |
| SNOA | Sonoma Pharmaceuticals, Inc. | $6.03M | $1.26 | — |
| STME | Stimcell Energetics Inc. | $5.83M | $0.28 | — |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | $5.74M | $6.71 | — |
| WOK | WORK Medical Technology Group LTD | $5.56M | $2.30 | — |
News headlines (Yahoo Finance, 1h cache)
Vivos Therapeutics (VVOS) Stock Sees Fair Value Moves Lower As Analysts Reset Growth Assumptions
2026-07-03 13:17 · Yahoo
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
2026-06-30 12:45 · Yahoo
Sector Update: Healthcare Stocks Rise Late Afternoon
2026-06-22 19:43 · Yahoo
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
2026-06-22 12:30 · Yahoo
Vivos Therapeutics Plans to File for Proposed Rights Offering
2026-06-11 13:11 · Yahoo
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
2026-06-11 12:30 · Yahoo
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
2026-06-10 13:03 · Yahoo
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
2026-06-08 17:39 · Yahoo
Sector Update: Healthcare Stocks Higher Late Afternoon
2026-06-05 19:49 · Yahoo
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
2026-06-05 12:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.